Preclinical models for defining efficacy of drug combinations: mapping the road to the clinic.
Gitler
Miriam S
MS
Developmental Therapeutics Program, National Cancer Institute, NIH, Rockville, MD 20852, USA. mgitler@novaresearch.com
Monks
Anne
A
Sausville
Edward A
EA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018929:Cell Culture Techniques; D004353:Drug Evaluation, Preclinical / Q000379:methods* / Q000592:standards; D004354:Drug Screening Assays, Antitumor / Q000379:methods; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents